# Tirzepatide and Semaglutide in Routine Care: 12-Month Weight in All of Us

An All of Us cohort compared five GLP-1 drugs. Few tirzepatide users had a weight recorded near the one-year mark.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/outside-the-trial-semaglutide-managed-six-percent
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Tirzepatide and Semaglutide in Routine Care: 12-Month Weight in All of Us

In All of Us records, year-one weight loss averaged 5.9% with semaglutide and 13.0% with tirzepatide among people with measurements.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20263 min readUpdated November 2026

Mean weight change at 12 months, routine US care · tirzepatide · −13% · semaglutide · −5.9% · the older three · −4% · 14,046 people. The trials report far larger numbers.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

When comparing [weight loss across GLP-1 trials](https://buythisglp.com/research/how-much-weight-will-i-lose-on-a-glp1) with routine care, check who had a follow-up weight. In this study, year-one measurements were sparse, especially for tirzepatide [\[1\]](https://buythisglp.com/research/outside-the-trial-semaglutide-managed-six-percent#ref-1).

## What the All of Us study measured

The cohort included 14,046 adults with obesity starting one of five drugs. The year-one analysis used recorded weights within 45 days of day 365 [\[1\]](https://buythisglp.com/research/outside-the-trial-semaglutide-managed-six-percent#ref-1).

That window included 1,476 of 5,656 semaglutide starters (26.1%). Fewer than 20 of 386 tirzepatide starters had a weight in the window. The study reported a mean loss of 5.9% for semaglutide and 13.0% for tirzepatide.

## Why the missing weights matter

Participants with a recorded weight may differ from those without one. The comparison used medical records without randomly assigning a drug. Differences in patients, treatment or follow-up could affect the estimates.

Access can affect whether a treatment plan is practical. In our [knownwell review](https://buythisglp.com/reviews/knownwell), the available visit formats illustrate one practical access consideration. The All of Us study did not compare providers or visit formats.

The researchers also estimated how quickly people reached 15% weight loss. Compared with liraglutide, adjusted hazard ratios were 1.77 for semaglutide and 5.57 for tirzepatide [\[1\]](https://buythisglp.com/research/outside-the-trial-semaglutide-managed-six-percent#ref-1). A hazard ratio measures relative rates over time.

## Frequently asked

How many participants had a year-one weight?

For semaglutide, 1,476 of 5,656 had a recorded weight near one year. For tirzepatide, fewer than 20 of 386 did.

Why are these estimates different from those in trials?

Routine care differs from a trial in its patient population, treatment and follow-up. This study cannot isolate those effects.

## Sources

1.  \[1\] Hwang I, Lee SW, Kim Y (2026). Real-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study Drug Design, Development and Therapy. [PMID 42518911](https://pmc.ncbi.nlm.nih.gov/articles/PMC13381347/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
